new strategy seeks to increase size and diversity of sample population
The FDA has announced plans to change its experimental study on gluten-free food product labeling. While the FDA still intends to pursue this important research, the recent modifications seek to open the study to a larger group of individuals. According to an FDA statement, these alterations will effectively ensure that data collected from the study more accurately reflect the entire population of American consumers.
The FDA’s Gluten-Free Labeling of Food Products Experimental Study, seeks to gauge perceptions regarding the many different gluten-free food indicators and labels currently found on food products, as well as consumer understanding of ‘gluten-free’ foods.
The FDA first proposed this preliminary investigation back in March 2009. Researchers initially planned to collect data only from consumers suffering from celiac disease or gluten-intolerance. However, the recent revisions now open the study to those who do not have either condition.
For additional details on changes to the FDA study on gluten-free labeling, as well as researchers initial findings, click here.